NASDAQ
ENTX

Entera Bio Ltd

(NO DISGNOSTIC SUBSTANCES)
LIFE SCIENCES

Prices are adjusted according to historical splits.

Entera Bio Ltd Stock Price

Vitals

Today's Low:
$0.6800
Today's High:
$0.7800
Open Price:
$0.7600
52W Low:
$0.688
52W High:
$4.23
Prev. Close:
$0.7600
Volume:
81056

Company Statistics

Market Cap.:
$0.020 billion
Book Value:
0.599
Revenue TTM:
$0.000 billion
Operating Margin TTM:
-3451%
Gross Profit TTM:
$0.000 billion
Gross Profit TTM:
$0.000 billion
Profit Margin:
0%
Return on Assets TTM:
-37.5%
Return on Equity TTM:
-67.1%

Company Profile

Entera Bio Ltd had its IPO on 2018-06-28 under the ticker symbol ENTX.

The company operates in the LIFE SCIENCES sector and (NO DISGNOSTIC SUBSTANCES) industry. Entera Bio Ltd has a staff strength of 0 employees.

Stock update

Shares of Entera Bio Ltd opened at $0.76 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.68 - $0.78, and closed at $0.7.

This is a -7.89% slip from the previous day's closing price.

A total volume of 81,056 shares were traded at the close of the day’s session.

In the last one week, shares of Entera Bio Ltd have slipped by -30%.

Entera Bio Ltd's Key Ratios

Entera Bio Ltd has a market cap of $0.020 billion, indicating a price to book ratio of 1.335 and a price to sales ratio of 48.36.

In the last 12-months Entera Bio Ltd’s revenue was $0.000 billion with a gross profit of $0.000 billion and an EBITDA of $-0.014 billion. The EBITDA ratio measures Entera Bio Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Entera Bio Ltd’s operating margin was -3451% while its return on assets stood at -37.5% with a return of equity of -67.1%.

In Q2, Entera Bio Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 59.6%.

Entera Bio Ltd’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-0.491 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Entera Bio Ltd’s profitability.

Entera Bio Ltd stock is trading at a EV to sales ratio of 14.26 and a EV to EBITDA ratio of -0.415. Its price to sales ratio in the trailing 12-months stood at 48.36.

Entera Bio Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Entera Bio Ltd ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Entera Bio Ltd ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Entera Bio Ltd’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Entera Bio Ltd's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Entera Bio Ltd paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.7
52-Week High
$4.23
52-Week Low
$0.688
Analyst Target Price
$7.5

Entera Bio Ltd stock is currently trading at $0.7 per share. It touched a 52-week high of $4.23 and a 52-week low of $4.23. Analysts tracking the stock have a 12-month average target price of $7.5.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Entera Bio Ltd

The stock symbol (also called stock or share ticker) of Entera Bio Ltd is ENTX

The IPO of Entera Bio Ltd took place on 2018-06-28

Similar Industry Stocks ((NO DISGNOSTIC SUBSTANCES))

Last Price
Chg
Chg%
$3.82
-0.32
-7.73%
$0.82
0.06
+7.76%
$1.24
-0.06
-4.49%
$1.73
-0.04
-2.26%
$1.98
-0.08
-3.88%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally administered large molecule therapies for unmet medical needs. The company is headquartered in Jerusalem, Israel.

Address

KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, IL